In this webcast professionals from KPMG, J.P. Morgan, and Nasdaq provide their insights and perspectives on the IPO market for the life sciences industry.
Topics discussed on this webcast include:
- Capital markets update for the life sciences industry
- Impact of COVID-19 on the life sciences ecosystem
- IPO market dynamics: potential “IPO windows” for the balance of 2020, the virtual IPO roadshow, and investor risk tolerance for new issuance
- Guidance for leaders at both late-stage life sciences companies (who hope to IPO in 2020) and early-stage life sciences companies (who are interested in an IPO down the road)